XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2018     54,738        
Beginning balance at Dec. 31, 2018 $ 1,885,070 $ 6,564 $ 547 $ 3,386,958 $ (3,627) $ (1,498,808) $ 6,564
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of restricted stock units (in shares)     131        
Vesting of restricted stock units 0   $ 2 (2)      
Exercise of stock options, shares (in shares)     189        
Exercise of stock options 9,504   $ 2 9,502      
Purchase of common stock under ESPP (in shares)     11        
Purchase of common stock under ESPP 1,231     1,231      
Stock-based compensation 32,341     32,341      
Other comprehensive loss 1,835       1,835    
Net loss (164,446)         (164,446)  
Ending balance, shares (in shares) at Mar. 31, 2019     55,069        
Ending balance at Mar. 31, 2019 1,772,099   $ 551 3,430,030 (1,792) (1,656,690)  
Beginning balance (in shares) at Dec. 31, 2018     54,738        
Beginning balance at Dec. 31, 2018 1,885,070 $ 6,564 $ 547 3,386,958 (3,627) (1,498,808) $ 6,564
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive loss 2,808            
Net loss (360,228)            
Ending balance, shares (in shares) at Jun. 30, 2019     55,228        
Ending balance at Jun. 30, 2019 1,636,374   $ 553 3,489,112 (819) (1,852,472)  
Beginning balance (in shares) at Mar. 31, 2019     55,069        
Beginning balance at Mar. 31, 2019 1,772,099   $ 551 3,430,030 (1,792) (1,656,690)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of restricted stock units (in shares)     66        
Vesting of restricted stock units 0   $ 1 (1)      
Exercise of stock options, shares (in shares)     93        
Exercise of stock options 3,973   $ 1 3,972      
Stock-based compensation 55,111     55,111      
Other comprehensive loss 973       973    
Net loss (195,782)         (195,782)  
Ending balance, shares (in shares) at Jun. 30, 2019     55,228        
Ending balance at Jun. 30, 2019 $ 1,636,374   $ 553 3,489,112 (819) (1,852,472)  
Beginning balance (in shares) at Dec. 31, 2019 55,368   55,368        
Beginning balance at Dec. 31, 2019 $ 1,284,993   $ 554 3,568,184 (1,893) (2,281,852)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of restricted stock units (in shares)     204        
Vesting of restricted stock units 0   $ 2 (2)      
Exercise of stock options, shares (in shares)     20        
Exercise of stock options 750     750      
Purchase of common stock under ESPP (in shares)     28        
Purchase of common stock under ESPP 1,872     1,872      
Stock-based compensation 36,335     36,335      
Other comprehensive loss (906)       (906)    
Net loss (202,611)         (202,611)  
Ending balance, shares (in shares) at Mar. 31, 2020     55,620        
Ending balance at Mar. 31, 2020 $ 1,120,433   $ 556 3,607,139 (2,799) (2,484,463)  
Beginning balance (in shares) at Dec. 31, 2019 55,368   55,368        
Beginning balance at Dec. 31, 2019 $ 1,284,993   $ 554 3,568,184 (1,893) (2,281,852)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options, shares (in shares) 27            
Other comprehensive loss $ (507)            
Net loss $ (224,076)            
Ending balance, shares (in shares) at Jun. 30, 2020 66,196   66,196        
Ending balance at Jun. 30, 2020 $ 1,682,031   $ 662 4,189,697 (2,400) (2,505,928)  
Beginning balance (in shares) at Mar. 31, 2020     55,620        
Beginning balance at Mar. 31, 2020 1,120,433   $ 556 3,607,139 (2,799) (2,484,463)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon public offering, net of issuance costs (in shares)     10,455        
Issuance of common stock upon public offering, net of issuance costs of $33,465 541,536   $ 105 541,431      
Vesting of restricted stock units (in shares)     114        
Vesting of restricted stock units 0   $ 1 (1)      
Exercise of stock options, shares (in shares)     7        
Exercise of stock options 347     347      
Stock-based compensation 40,781     40,781      
Other comprehensive loss 399       399    
Net loss $ (21,465)         (21,465)  
Ending balance, shares (in shares) at Jun. 30, 2020 66,196   66,196        
Ending balance at Jun. 30, 2020 $ 1,682,031   $ 662 $ 4,189,697 $ (2,400) $ (2,505,928)